Parallax Volatility Advisers
BIB icon

Parallax Volatility Advisers’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Parallax Volatility Advisers’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2
Closed – – 2337
2019
Q2 		$0 Hold
2
– – ﹤0.01% 2572
2019
Q1 		$0 Hold
2
– – ﹤0.01% 2789
2018
Q4 		$0 Hold
2
– – ﹤0.01% 2922
2018
Q3 		$0 Hold
2
– – ﹤0.01% 2587
2018
Q2 		$0 Hold
2
– – ﹤0.01% 2128
2018
Q1 		$0 Hold
2
– – ﹤0.01% 2319
2017
Q4 		$0 Hold
2
– – ﹤0.01% 3957
2017
Q3 		$0 Hold
2
– – ﹤0.01% 2100
2017
Q2 		$0 Hold
2
– – ﹤0.01% 2297
2017
Q1 		$0 Hold
2
– – ﹤0.01% 3552
2016
Q4 		$0 Hold
2
– – ﹤0.01% 3053
2016
Q3 		$0 Hold
2
– – ﹤0.01% 2875
2016
Q2 		$0 Hold
2
– – ﹤0.01% 2514
2016
Q1 		$0 Hold
2
– – ﹤0.01% 2511
2015
Q4 		$0 Hold
2
– – ﹤0.01% 2870
2015
Q3 		$0 Hold
2
– – ﹤0.01% 2868
2015
Q2 		$0 Hold
2
– – ﹤0.01% 3614
2015
Q1 		$0 Hold
2
– – ﹤0.01% 4389
2014
Q4 		$0 Buy
+2
New +$117 ﹤0.01% 5004

Other funds holding BIB

CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CAL
Capital Analysts LLC Fort Washington, Pennsylvania $3.81B AUM 15.52% 1-Year Est. Return

Parallax Volatility Advisers's BIB Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2019, closing a stake of 2 shares.

Parallax Volatility Advisers first reported a position in BIB in Q4 2014 and held it in 19 quarters. The position peaked at $0 in Q2 2019. 25 funds tracked by Wall St. Rank hold BIB as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2 ProShares Ultra NASDAQ Biotechnology shares in Q3 2019.
  • Parallax Volatility Advisers first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2014 and held it in 19 quarters.
  • Parallax Volatility Advisers's ProShares Ultra NASDAQ Biotechnology position peaked at $0 in Q2 2019.
  • 25 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.